CALA
CALITHERA BIOSCIENCES INC
stockOTC
calithera is focused on discovering and developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells. tumor metabolism and tumor immunology are promising new interrelated fields for cancer drug discovery. recent clinical successes have demonstrated the potential to slow abnormal cell growth and create fundamentally new therapies for cancer patients. our investigational onco-metabolism medicines take advantage of the different metabolic requirements of tumor cells and cancer-fighting immune cells. calithera's discovery and development efforts are focused on solid tumors for which new treatments are urgently needed. we are currently developing our lead candidate in phase 2 trials in patients with renal cell carcinoma, triple negative breast cancer. targeting cancer, differently. our onco-metabolism approach brings an enhanced perspective to cancer.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 3M | 0.00 | 2026-08-03 | -66.67% | -247.546 |
| 6M | 0.00 | 2026-05-05 | -66.67% | -176.360 |
| 1Y | 0.00 | 2025-11-03 | -90.00% | -91.348 |
| 2Y | 0.01 | 2024-10-31 | -98.57% | — |
| 5Y | 38.40 | 2021-11-03 | -100.00% | -8.689 |
CALITHERA BIOSCIENCES INC (OTC:CALA) stock price today is $0.00, and today's volume is 1,841. CALA is down 66.667% today. The 30 day average volume is 711. CALA market cap is $487 with 4.87M shares outstanding.